US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class I · High risk Terminated

Alcohol Antiseptic 80%

Reason Chemical Contamination: FDA testing found Presence of methanol

Jarman's Midwest Cleaning Systems, Inc. D-0873-2023
Class II · Moderate risk Terminated

Isopropyl Alcohol Antiseptic 75%

Reason CGMP deficiencies: Product manufactured at the same site where FDA testing found Presence of methanol in other products.

Jarman's Midwest Cleaning Systems, Inc. D-0872-2023
Class III · Low risk Terminated

Bevacizumab 2.5 mg/0.1 mL

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Pine Pharmaceuticals, LLC NDC 69194-0458-1 D-0531-2023
Class III · Low risk Terminated

Montelukast Sodium Oral Granules USP

Reason Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

Teva Pharmaceuticals USA Inc NDC 0093-7487-56 D-0510-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7596-3 D-0506-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7595-3 D-0505-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7594-3 D-0504-2023
Class II · Moderate risk Terminated

Simvastatin 40 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0060-01 D-0503-2023
Class II · Moderate risk Terminated

Rosuvastatin 40mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1311-01 D-0502-2023
Class II · Moderate risk Terminated

Rosuvastatin 10mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0375-03 D-0501-2023
Class II · Moderate risk Terminated

Rosuvastatin 5mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-3519-00 D-0500-2023
Class II · Moderate risk Terminated

Ropinirole 2mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2750-00 D-0499-2023
Class II · Moderate risk Terminated

Atorvastatin 20 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1977-00 D-0498-2023
Class II · Moderate risk Terminated

Tadalafil 5 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2972-00 D-0497-2023
Class II · Moderate risk Terminated

Simvastatin 10 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0064-01 D-0496-2023
Class II · Moderate risk Terminated

Rosuvastatin 5mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-3519-00 D-0495-2023
Class II · Moderate risk Terminated

Ropinirole 0.5 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2439-00 D-0494-2023
Class II · Moderate risk Terminated

Glimepiride 2 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0405-03 D-0493-2023
Class II · Moderate risk Terminated

Doxazosin 2 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1560-00 D-0492-2023
Class II · Moderate risk Terminated

Atorvastatin 10 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1946-00 D-0491-2023
Class II · Moderate risk Terminated

Aripiprazole 5mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2921-03 D-0490-2023
Class II · Moderate risk Terminated

Glimepiride Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Amerisource Health Services LLC NDC 68001-179-00 D-0759-2023
Class II · Moderate risk Terminated

Glimepiride Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Amerisource Health Services LLC NDC 68001-178-00 D-0758-2023
Class II · Moderate risk Terminated

Glimepiride Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Amerisource Health Services LLC NDC 68001-177-00 D-0757-2023
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: Out of specification dissolution results above specified values.

Amerisource Health Services LLC D-0536-2023